ArticleScientific reports2026

Rosuvastatin attenuates tubulointerstitial fibrosis by targeting the HOXA13 USAG1 BMP7 pathway.

Donghwan Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.